mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.03 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |
mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.03 |